It's time to phase in<i><scp>RHD</scp></i>genotyping for patients with a serologic weak<scp>D</scp>phenotypeS. Gerald Sandler, Clayton D. Simon, Willy A. Flegel et al.|Transfusion|2014Cited by 195
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W. Senefeld, Janis E. Blair, Noud van Helmond et al.|PLoS Medicine|2021Cited by 65